hubbab

Long Genocea Biosciences when the price has fallen to last lows

Long
NASDAQ:GNCA   None
0
"Genocea Biosciences Inc is a clinical stage biopharmaceutical company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today."

Potential risk:

"Company Insider Jessica Baker Flechtner (Sr. VP of Research) Sells 2,229 Shares of Genocea Biosciences, Inc. (GNCA). The Insider selling transaction was disclosed on Jun 2, 2015 to the Securities and Exchange Commission. "

thedailyrover.com/co...iosciences-inc-gnca/
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.